
产品介绍 评论(0)
物种
Mouse分子别名
Txgp1; OX40L receptor; ACT35Accession
P47741表达序列
Val20-Pro211, with C-terminal His表达宿主
HEK293分子量
43-50kDa (Reducing)
纯度
>95% by SDS-PAGE内毒素含量
<0.1EU/μg标记
Unconjugated标签
His Tag性状
Lyophilized Powder缓冲体系
PBS, pH7.4.溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
储存条件
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
文献引用
1. Cancer Res. Roles of OX40 in the pathogenesis and the control of diseases.Int J Hematol. 2006 Jan;83(1):17-22. Toshiyuki Hori.
OX40 belongs to the tumor necrosis factor receptor superfamily, and its expression is restricted to activated T-cells. Ligation of OX40 during T-cell-dendritic cell interaction is crucial for clonal expansion of antigen-specific T-cells and generation of T-cell memory. Recent studies with animal models have indicated the critical involvement of OX40 in the pathogenesis of a variety of immunologic abnormalities of inflammatory, autoimmune, infectious, allergic, and allotransplantation-related diseases. Blockade of OX40-OX40L(The ligand of OX40) interaction has been shown to prevent, cure, or ameliorate these diseases. In contrast, activation of OX40 is known to break an existing state of tolerance in malignancies, leading to a reactivation of antitumor immunity. These findings clearly suggest that the OX40/OX40L system is one of the most promising targets of immune intervention for treatment of these diseases.
电泳
1μg (R: reducing condition, N: non-reducing condition).
ELISA
Immobilized OX40/TNFRSF4/CD134 His Tag, Mouse (Cat. No. UA010805) at 2.0μg/mL (100μL/well) can bind Biotinylated Mouse OX40 Ligand / TNFSF4 Protein, His Tag with EC50 of 41.05-90.04ng/mL.







评论(0)